Maciej Michalak, Piotr Tomczak, T. Milecki, Andrzej Antczak
{"title":"肾切除术后接受舒尼替尼治疗的转移性肾细胞癌患者的治疗效果、实验室结果、不良反应和癌症治疗耐受性","authors":"Maciej Michalak, Piotr Tomczak, T. Milecki, Andrzej Antczak","doi":"10.5603/njo.98971","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":130080,"journal":{"name":"Nowotwory. Journal of Oncology","volume":" 73","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Outcomes of treatment, laboratory results, adverse effects, and tolerability of cancer treatment in patients with metastatic renal cell carcinoma treated with sunitinib after cytoreductive nephrectomy\",\"authors\":\"Maciej Michalak, Piotr Tomczak, T. Milecki, Andrzej Antczak\",\"doi\":\"10.5603/njo.98971\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":130080,\"journal\":{\"name\":\"Nowotwory. Journal of Oncology\",\"volume\":\" 73\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nowotwory. Journal of Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/njo.98971\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nowotwory. Journal of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/njo.98971","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Outcomes of treatment, laboratory results, adverse effects, and tolerability of cancer treatment in patients with metastatic renal cell carcinoma treated with sunitinib after cytoreductive nephrectomy